Heat shock proteins: Pathogenic role in atherosclerosis and potential therapeutic implications

Autoimmune Diseases

Volumn 1, Issue 1, 2012, Pages

  Kilic, Arman ^a   Mandal, Kaushik ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CHAPERONIN 60; EARLY PREGNANCY FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY TITER; APOPTOSIS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURFACE; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; META ANALYSIS; MOLECULAR WEIGHT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGNOSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; SYSTEMATIC REVIEW;

EID: 84872146402     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2012/502813     Document Type: Review

References (83)

1. Milkman R., Temperature effects on day old Drosophila pupae. The Journal of General Physiology 1962 45 777 799 2-s2.0-0006567493
2. Morimoto R. I., Cells in stress: transcriptional activation of heat shock genes. Science 1993 259 5100 1409 1410 2-s2.0-0027522356 (Pubitemid 23101373)
3. Madrigal-Matute J., Martin-Ventura J. L., Blanco-Colio L. M., Egido J., Michel J. B., Meilhac O., Heat-shock proteins in cardiovascular disease. Advances in Clinical Chemistry 2011 54 1 43 2-s2.0-79953876832 10.1016/B978-0-12-387025-4.00001-7
4. Xu Q., Metzler B., Jahangiri M., Mandal K., Molecular chaperones and heat shock proteins in atherosclerosis. American Journal of Physiology 2012 302 3 H506 H514 2-s2.0-84856022421 10.1152/ajpheart.00646.2011
5. Bielecka-Dabrowa A., Barylski M., Mikhailidis D. P., Rysz J., Banach M., HSP 70 and atherosclerosis-protector or activator? Expert Opinion on Therapeutic Targets 2009 13 3 307 317 2-s2.0-65549134708 10.1517/14728220902725149
6. Xu Q., Biomechanical-stress-induced signaling and gene expression in the development of arteriosclerosis. Trends in Cardiovascular Medicine 2000 10 1 35 41 2-s2.0-0034528549 10.1016/S1050-1738(00)00042-6 (Pubitemid 32012679)
7. Hartl F. U., Heat shock proteins in protein folding and membrane translocation. Seminars in Immunology 1991 3 1 5 16 2-s2.0-0025931304
8. Roma P., Catapano A. L., Stress proteins and atherosclerosis. Atherosclerosis 1996 127 2 147 154 2-s2.0-0030596054 10.1016/S0021-9150(96) 05952-7 (Pubitemid 27045828)
9. Nielsen K. L., Cowan N. J., A single ring is sufficient for productive chaperonin-mediated folding in vivo. Molecular Cell 1998 2 1 93 99 2-s2.0-0032113635 (Pubitemid 128378970)
10. Voss M. R., Stallone J. N., Li M., Cornelussen R. N. M., Knuefermann P., Knowlton A. A., Gender differences in the expression of heat shock proteins: the effect of estrogen. American Journal of Physiology 2003 285 2 H687 H692 2-s2.0-0037623868 (Pubitemid 36885901)
11. Rayner K., Chen Y. X., Siebert T., O'Brien E. R., Heat shock protein 27: clue to understanding estrogen-mediated atheroprotection? Trends in Cardiovascular Medicine 2010 20 2 54 58 2-s2.0-79955091989
12. Shimizu M., Tamamori-Adachi M., Arai H., Tabuchi N., Tanaka H., Sunamori M., Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory B α complex and attenuation of nuclear factor B. Journal of Thoracic and Cardiovascular Surgery 2002 124 5 933 941 2-s2.0-0036828745 10.1067/mtc.2002.122305 (Pubitemid 35253241)
13. Pratt W. B., Toft D. O., Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Experimental Biology and Medicine 2003 228 2 111 133 2-s2.0-0037315208 (Pubitemid 36187918)
14. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q., Is atherosclerosis an immunologically mediated disease? Immunology Today 1995 16 1 27 33 2-s2.0-0028816015 10.1016/0167-5699(95)80067-0
15. Giannessi D., Colotti C., Maltinti M., Del Ry S., Prontera C., Turchi S., L'Abbate A., Neglia D., Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress and Chaperones 2007 12 3 265 274 2-s2.0-35348854947 10.1379/CSC-272.1 (Pubitemid 351199389)
16. Young R. A., Elliott T. J., Stress proteins, infection, and immune surveillance. Cell 1989 59 1 5 8 2-s2.0-0024418447 (Pubitemid 19248553)
17. Wick G., Kleindienst R., Schett G., Amberger A., Xu Q., Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. International Archives of Allergy and Immunology 1995 107 1-3 130 131 2-s2.0-0029015527
18. Amberger A., Maczek C., Jürgens G., Michaelis D., Schett G., Trieb K., Eberl T., Jindal S., Xu Q., Wick G., Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress and Chaperones 1997 2 2 94 103 2-s2.0-0030815915 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3. CO;2 (Pubitemid 27290318)
19. Kol A., Bourcier T., Lichtman A. H., Libby P., Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. The Journal of Clinical Investigation 1999 103 4 571 577 2-s2.0-0033557202 (Pubitemid 29094058)
20. Rossmann A., Henderson B., Heidecker B., Seiler R., Fraedrich G., Singh M., Parson W., Keller M., Grubeck-Loebenstein B., Wick G., T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Experimental Gerontology 2008 43 3 229 237 2-s2.0-39149117982 10.1016/j.exger.2007.11.009
21. Knoflach M., Kiechl S., Kind M., Said M., Sief R., Gisinger M., Van der Zee R., Gaston H., Jarosch E., Willeit J., Wick G., Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 2003 108 9 1064 1069 2-s2.0-0042818096 10.1161/01.CIR.0000085996.95532.FF (Pubitemid 37071515)
22. Major A. S., Fazio S., Linton M. F., B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 11 1892 1898 2-s2.0-0036847364 10.1161/01.ATV. 0000039169.47943.EE (Pubitemid 35315778)
23. Caligiuri G., Nicoletti A., Poirierand B., Hansson G. K., Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. The Journal of Clinical Investigation 2002 109 6 745 753 2-s2.0-0036193513 10.1172/JCI200207272 (Pubitemid 34263151)
24. Kyaw T., Tay C., Khan A., Dumouchel V., Cao A., To K., Kehry M., Dunn R., Agrotis A., Tipping P., Bobik A., Toh B. H., Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. The Journal of Immunology 2010 185 7 4410 4419 2-s2.0-77958125881 10.4049/jimmunol.1000033
25. Greaves D. R., Channon K. M., Inflammation and immune responses in atherosclerosis. Trends in Immunology 2002 23 11 535 541 2-s2.0-0036839228 10.1016/S1471-4906(02)02331-1 (Pubitemid 35223552)
26. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., Willeit J., Kiechl S., Wick G., Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000 102 1 14 20 2-s2.0-0034604242 (Pubitemid 30430547)
27. Kol A., Sukhova G. K., Lichtman A. H., Libby P., Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor- α and matrix metalloproteinase expression. Circulation 1998 98 4 300 307 2-s2.0-0032575305 (Pubitemid 28348051)
28. Dybdahl B., Slørdahl S. A., Waage A., Kierulf P., Espevik T., Sundan A., Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005 91 3 299 304 2-s2.0-14244250847 10.1136/hrt.2003.028092 (Pubitemid 40299205)
29. Xiao Q., Mandal K., Schett G., Mayr M., Wick G., Oberhollenzer F., Willeit J., Kiechl S., Xu Q., Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 2005 36 12 2571 2576 2-s2.0-33644672632 10.1161/01.STR.0000189632. 98944.ab
30. Satoh M., Shimoda Y., Akatsu T., Ishikawa Y., Minami Y., Nakamura M., Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. European Journal of Heart Failure 2006 8 8 810 815 2-s2.0-33751165458 10.1016/j.ejheart.2006.03.004 (Pubitemid 44779418)
31. Gombos T., Förhécz Z., Pozsonyi Z., Jánoskuti L., Prohászka Z., Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress and Chaperones 2008 13 2 199 206 2-s2.0-67349221033 10.1007/s12192-007-0001-5
32. Zhang X., He M., Cheng L., Chen Y., Zhou L., Zeng H., Pockley A. G., Hu F. B., Wu T., Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation 2008 118 25 2687 2693 2-s2.0-58249136301 10.1161/CIRCULATIONAHA.108.781856
33. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., Stulnig T., Luef G., Wick G., Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. The Lancet 1993 341 8840 255 259 2-s2.0-0027399854 10.1016/0140-6736(93)92613-X (Pubitemid 23038021)
34. Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., Willeit J., Wick G., Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999 100 11 1169 1174 2-s2.0-0033554448 (Pubitemid 29426591)
35. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q., Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000 102 8 833 839 2-s2.0-0034702910
36. Huittinen T., Leinonen M., Tenkanen L., Mänttäri M., Virkkunen H., Pitkänen T., Wahlström E., Palosuo T., Manninen V., Saikku P., Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 431 437 2-s2.0-0036121482 10.1161/hq0302.104512 (Pubitemid 34218750)
37. Reszka E., Jegier B., Wasowicz W., Lelonek M., Banach M., Jaszewski R., Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovascular Pathology 2008 17 5 297 302 2-s2.0-49249121794 10.1016/j.carpath.2007.11.002
38. Foteinos G., Afzal A. R., Mandal K., Jahangiri M., Xu Q., Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 2005 112 8 1206 1213 2-s2.0-24044547060 10.1161/CIRCULATIONAHA.105.547414 (Pubitemid 41216128)
39. George J., Afek A., Gilburd B., Shoenfeld Y., Harats D., Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. Journal of the American College of Cardiology 2001 38 3 900 905 2-s2.0-0034857562 10.1016/S0735-1097(01) 01440-1 (Pubitemid 32835770)
40. Xu Q., Dietrich H., Steiner H. J., Gown A. M., Schoel B., Mikuz G., Kaufmann S. H. E., Wick G., Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arteriosclerosis and Thrombosis 1992 12 7 789 799 2-s2.0-0026683392
41. Metzler B., Mayr M., Dietrich H., Singh M., Wiebe E., Xu Q., Wick G., Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 8 1905 1911 2-s2.0-0032796502 (Pubitemid 29379920)
42. Hansen J. J., Bross P., Westergaard M., Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Human Genetics 2003 112 1 71 77 2-s2.0-0037932576 10.1007/s00439-002-0837-9 (Pubitemid 36869118)
43. Shan Y. X., Liu T. J., Su H. F., Samsamshariat A., Mestril R., Wang P. H., Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. Journal of Molecular and Cellular Cardiology 2003 35 9 1135 1143 2-s2.0-0042330503 10.1016/S0022-2828(03) 00229-3 (Pubitemid 37083257)
44. Badrichani A. Z., Stroka D. M., Bilbao G., Curiel D. T., Bach F. H., Ferran C., Bcl-2 and Bcl-X(L) serve an anti-inflammatory function in endothelial cells through inhibition of NF- B. The Journal of Clinical Investigation 1999 103 4 543 553 2-s2.0-0033557372 (Pubitemid 29094055)
45. Ciervo A., Petrucca A., Villano U., Fioroni G., Cassone A., Low prevalence of antibodies against heat shock protein 10 of Chlamydophila pneumoniae in patients with coronary heart disease. Journal of Microbiological Methods 2005 63 3 248 253 2-s2.0-27744482894 10.1016/j.mimet.2005.03.011 (Pubitemid 41597369)
46. Park H. K., Park E. C., Bae S. W., Park M. Y., Kim S. W., Yoo H. S., Tudev M., Ko Y. H., Choi Y. H., Kim S., Kim D. I., Kim Y. W., Lee B. B., Yoon J. B., Park J. E., Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006 114 9 886 893 2-s2.0-33748372961 10.1161/CIRCULATIONAHA.105.541219 (Pubitemid 44337131)
47. Martin-Ventura J. L., Duran M. C., Blanco-Colio L. M., Meilhac O., Leclercq A., Michel J. B., Jensen O. N., Hernandez-Merida S., Tuñón J., Vivanco F., Egido J., Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004 110 15 2216 2219 2-s2.0-20844438189 10.1161/01.CIR.0000136814.87170.B1 (Pubitemid 39372504)
48. De Souza A. I., Wait R., Mitchell A. G., Banner N. R., Dunn M. J., Rose M. L., Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circulation Research 2005 97 2 192 198 2-s2.0-22744445856 10.1161/01.RES.0000174815.10996.08 (Pubitemid 41033476)
49. Lijnen H. R., Plasmin and matrix metalloproteinases in vascular remodeling. Thrombosis and Haemostasis 2001 86 1 324 333 2-s2.0-0034927107 (Pubitemid 32663963)
50. Lepedda A. J., Cigliano A., Cherchi G. M., Spirito R., Maggioni M., Carta F., Turrini F., Edelstein C., Scanu A. M., Formato M., A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009 203 1 112 118 2-s2.0-60949088459 10.1016/j.atherosclerosis.2008.07.001
51. Guay J., Lambert H., Gingras-Breton G., Lavoie J. N., Huot J., Landry J., Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. Journal of Cell Science 1997 110 3 357 368 2-s2.0-0031056783 (Pubitemid 27095655)
52. Martin-Ventura J. L., Nicolas V., Houard X., Blanco-Colio L. M., Leclercq A., Egido J., Vranckx R., Michel J. B., Meilhac O., Biological significance of decreased HSP27 in human atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 6 1337 1343 2-s2.0-33745033143 10.1161/01.ATV. 0000220108.97208.67 (Pubitemid 44305379)
53. Rayner K., Chen Y. X., McNulty M., Simard T., Zhao X., Wells D. J., De Belleroche J., O'Brien E. R., Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-a. Circulation Research 2008 103 2 133 141 2-s2.0-48849088564 10.1161/CIRCRESAHA.108.172155
54. Miller H., Poon S., Hibbert B., Rayner K., Chen Y. X., O'Brien E. R., Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 e10 e14 2-s2.0-27744519263
55. Liu P. Y., Christian R. C., Ruan M., Miller V. M., Fitzpatrick L. A., Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. Journal of Clinical Endocrinology and Metabolism 2005 90 2 1041 1046 2-s2.0-14044264293 10.1210/jc.2004-1211 (Pubitemid 40279231)
56. Christian R. C., Liu P. Y., Harrington S., Ruan M., Miller V. M., Fitzpatrick L. A., Intimal estrogen Receptor (ER) β but Not ER α expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2006 91 7 2713 2720 2-s2.0-33745792191 10.1210/jc.2005-2672 (Pubitemid 44024642)
57. Bobryshev Y. V., Lord R. S. A., Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. Journal of Vascular Surgery 2002 35 2 368 375 2-s2.0-0036484840 10.1067/mva.2002.121067 (Pubitemid 46098526)
58. Han Z., Truong Q. A., Park S., Breslow J. L., Two Hsp70 family members expressed in atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1256 1261 2-s2.0-0037418010 10.1073/pnas.252764399 (Pubitemid 36183989)
59. Svensson P. A., Asea A., Englund M. C. O., Bausero M. A., Jernås M., Wiklund O., Ohlsson B. G., Carlsson L. M. S., Carlsson B., Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages. Atherosclerosis 2006 185 1 32 38 2-s2.0-30944453701 10.1016/j.atherosclerosis.2005.05.007 (Pubitemid 43117548)
60. Wendling U., Paul L., Van Der Zee R., Prakken B., Singh M., Van Eden W., A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. The Journal of Immunology 2000 164 5 2711 2717 2-s2.0-0034163391 (Pubitemid 30115504)
61. Shimizu M., Tamamori-Adachi M., Arai H., Tabuchi N., Tanaka H., Sunamori M., Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory B α complex and attenuation of nuclear factor B. Journal of Thoracic and Cardiovascular Surgery 2002 124 5 933 941 2-s2.0-0036828745 10.1067/mtc.2002.122305 (Pubitemid 35253241)
62. Zhu J., Quyyumi A. A., Wu H., Csako G., Rott D., Zalles-Ganley A., Ogunmakinwa J., Halcox J., Epstein S. E., Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 6 1055 1059 2-s2.0-0038797792 10.1161/01.ATV.0000074899.60898.FD (Pubitemid 36713560)
63. Martin-Ventura J. L., Leclercq A., Blanco-Colio L. M., Egido J., Rossignol P., Meilhac O., Michel J. B., Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 2007 194 2 334 341 2-s2.0-34848881273 10.1016/j.atherosclerosis.2006.10.030 (Pubitemid 47513095)
64. Yao Y., Watson A. D., Ji S., Boström K. I., Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding Matrix Gla protein. Circulation Research 2009 105 6 575 584 2-s2.0-70349256058 10.1161/CIRCRESAHA.109.202333
65. Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., D'Amati G., Ippoliti F., Leopizzi M., D'Arcangelo D., Capoano R., Fumagalli L., Salvati B., Riganò R., Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009 207 1 74 83 2-s2.0-70350566676 10.1016/j.atherosclerosis.2009.04.026
66. Madrigal-Matute J., López-Franco O., Blanco-Colio L. M., Muñoz-García B., Ramos-Mozo P., Ortega L., Egido J., Martín-Ventura J. L., Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovascular Research 2010 86 2 330 337 2-s2.0-77951680995 10.1093/cvr/cvq046
67. Madrigal-Matute J., Fernandez-Garcia C. E., Gomez-Guerrero C., Lopez-Franco O., Muñoz-Garcia B., Egido J., Blanco-Colio L. M., Martin-Ventura J. L., HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. Cardiovascular Research 2012 95 1 116 123 2-s2.0-84867505151 10.1093/cvr/cvs158
68. Shimp III S. K., Chafin C. B., Regna N. L., Hammond S. E., Read M. A., Caudell D. L., Rylander M. N., Reilly C. M., Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cellular and Molecular Immunology 2012 9 3 255 266 2-s2.0-84861685780 10.1038/cmi.2012.5
69. Chatterjee A., Dimitropoulou C., Drakopanayiotakis F., Antonova G., Snead C., Cannon J., Venema R. C., Catravas J. D., Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. American Journal of Respiratory and Critical Care Medicine 2007 176 7 667 675 2-s2.0-34848829167 10.1164/rccm.200702-291OC (Pubitemid 47503074)
70. Birnie D. H., Holme E. R., McKay I. C., Hood S., McColl K. E. L., Hillis W. S., Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. European Heart Journal 1998 19 3 387 394 2-s2.0-0032032277 10.1053/euhj.1997.0618 (Pubitemid 28120718)
71. Barylski M., Małyszko J., Rysz J., Myśliwiec M., Banach M., Lipids, blood pressure, kidney-what was new in 2011? Archives of Medical Science 2011 7 6 1055 1066 2-s2.0-83455176743 10.5114/AOMS.2011.26620
72. Hoppichler F., Koch T., Dzien A., Gschwandtner G., Lechleitner M., Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 2000 94 4 220 223 2-s2.0-0034447972 10.1159/000047320 (Pubitemid 32402282)
73. Birnie D. H., Vickers L. E., Hillis W. S., Norrie J., Cobbe S. M., Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain. Heart 2005 91 9 1148 1153 2-s2.0-23944515730 10.1136/hrt.2004.040485 (Pubitemid 41192383)
74. Maron R., Sukhova G., Faria A. M., Hoffmann E., Mach F., Libby P., Weiner H. L., Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002 106 13 1708 1715 2-s2.0-0037167684 10.1161/01.CIR.0000029750.99462.30
75. Harats D., Yacov N., Gilburd B., Shoenfeld Y., George J., Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. Journal of the American College of Cardiology 2002 40 7 1333 1338 2-s2.0-0037010005 10.1016/S0735-1097(02)02135-6
76. Pilla L., Patuzzo R., Rivoltini L., Maio M., Pennacchioli E., Lamaj E., Maurichi A., Massarut S., Marchianò A., Santantonio C., Tosi D., Arienti F., Cova A., Sovena G., Piris A., Nonaka D., Bersani I., Di Florio A., Luigi M., Srivastava P. K., Hoos A., Santinami M., Parmiani G., A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon- α in metastatic melanoma patients. Cancer Immunology, Immunotherapy 2006 55 8 958 968 2-s2.0-33646348754 10.1007/s00262-005-0084-8 (Pubitemid 43673585)
77. Jun L., Jie L., Dongping Y., Xin Y., Taiming L., Rongyue C., Jie W., Jingjing L., Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis. Vaccine 2012 30 6 1029 1037 2-s2.0-84856363976 10.1016/j.vaccine.2011.12.043
78. Keijzer C., Wieten L., Van Herwijnen M., Van Der Zee R., Van Eden W., Broere F., Heat shock proteins are therapeutic targets in autoimmune diseases and other chronic inflammatory conditions. Expert Opinion on Therapeutic Targets 2012 16 9 849 857 2-s2.0-84865316534 10.1517/14728222.2012.706605
79. Ugurlucan M., Erer D., Kalko Y., Gungor F., Haholu A., Basaran M., Banach M., Rysz J., Mikhailidis D. P., Tireli E., Dayioglu E., Alpagut U., Aortic stiffness in diabetes mellitus-association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model. Expert Opinion on Therapeutic Targets 2009 13 3 267 274 2-s2.0-65549092757 10.1517/14728220902735833
80. Ishii T., Seike T., Nakashima T., Juliger S., Maharaj L., Soga S., Akinaga S., Cavenagh J., Joel S., Shiotsu Y., Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib. Blood Cancer Journal 2012 2 4, e68 2-s2.0-84864038902 10.1038/bcj.2012.13
81. Kaiser M., Kühnl A., Reins J., Fischer S., Ortiz-Tanchez J., Schlee C., Mochmann L. H., Heesch S., Benlasfer O., Hofmann W. K., Thiel E., Baldus C. D., Antileukemic activity of the HSP70 inhibitor pifithrin- in acute leukemia. Blood Cancer Journal 2011 1, article e28
82. Bernard Y., Ribeiro N., Thuaud F., Türkeri G., Dirr R., Boulberdaa M., Nebigil C. G., Désaubry L., Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27. PLoS ONE 2011 6 10 e25302 2-s2.0-80055110679 10.1371/journal.pone.0025302
83. Selimoglu O., Ugurlucan M., Basaran M., Gungor F., Banach M., Cucu O., Ong L. L., Gasparyan A. Y., Mikhailidis D., Ogus T. N., Efficacy of remote ischaemic preconditioning for spinal cord protection against ischaemic injury: association with heat shock protein expression. Folia Neuropathologica 2008 46 3 204 212 2-s2.0-55349102314